0000919574-11-002583.txt : 20110401
0000919574-11-002583.hdr.sgml : 20110401
20110401161331
ACCESSION NUMBER: 0000919574-11-002583
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20110401
DATE AS OF CHANGE: 20110401
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001484478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271197863
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-85529
FILM NUMBER: 11731454
BUSINESS ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-456-7800
MAIL ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: PPD Therapeutics, Inc.
DATE OF NAME CHANGE: 20100218
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: 683 Capital Management, LLC
CENTRAL INDEX KEY: 0001404574
IRS NUMBER: 205100992
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 595 MADISON AVENUE
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-554-2390
MAIL ADDRESS:
STREET 1: 595 MADISON AVENUE
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
SC 13G
1
d1195068_13d.txt
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )
Furiex Pharmaceuticals, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.001 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
36106P101
--------------------------------------------------------------------------------
(CUSIP Number)
March 11, 2011
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
--------------------------------------------------------------------------------
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 36106P101
---------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
683 Capital Management, LLC
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [X]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5. SOLE VOTING POWER
0
6. SHARED VOTING POWER
502,563
7. SOLE DISPOSITIVE POWER
0
8. SHARED DISPOSITIVE POWER
502,563
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
502,563
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[_]
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.09%
12. TYPE OF REPORTING PERSON
IA
CUSIP No. 36106P101
---------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
683 Capital Partners, LP
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [X]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5. SOLE VOTING POWER
0
6. SHARED VOTING POWER
502,563
7. SOLE DISPOSITIVE POWER
0
8. SHARED DISPOSITIVE POWER
502,563
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
502,563
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[_]
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.09%
12. TYPE OF REPORTING PERSON
PN
CUSIP No. 36106P101
--------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Ari Zweiman
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [X]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5. SOLE VOTING POWER
0
6. SHARED VOTING POWER
502,563
7. SOLE DISPOSITIVE POWER
0
8. SHARED DISPOSITIVE POWER
502,563
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
502,563
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[_]
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.09%
12. TYPE OF REPORTING PERSON
IN
CUSIP No. 36106P101
---------
Item 1(a). Name of Issuer:
Furiex Pharmaceuticals, Inc.
--------------------------------------------------------------------
Item 1(b). Address of Issuer's Principal Executive Offices:
3900 Paramount Parkway, Suite 150
Morrisville, North Carolina 27560
--------------------------------------------------------------------
Item 2(a). Name of Person Filing:
683 Capital Management, LLC
683 Capital Partners, LP
Ari Zweiman
--------------------------------------------------------------------
Item 2(b). Address of Principal Business Office, or if None, Residence:
683 Capital Management, LLC
595 Madison Avenue, 17th Floor
New York, New York 10022
683 Capital Partners, LP
595 Madison Avenue, 17th Floor
New York, New York 10022
Ari Zweiman
c/o 683 Capital Management, LLC
595 Madison Avenue, 17th Floor
New York, New York 10022
--------------------------------------------------------------------
Item 2(c). Citizenship:
683 Capital Management, LLC - Delaware limited liability company
683 Capital Partners, LP - Delaware limited partnership
Ari Zweiman - United States
--------------------------------------------------------------------
Item 2(d). Title of Class of Securities:
Common Stock, par value $0.001 per share
--------------------------------------------------------------------
Item 2(e). CUSIP Number:
36106P101
--------------------------------------------------------------------
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a:
(a) [_] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) [_] Investment company registered under Section 8 of the Investment
Company Act.
(e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) [_] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [_] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
683 Capital Management, LLC - 502,563
683 Capital Partners, LP - 502,563
Ari Zweiman - 502,563
--------------------------------------------------------------------
(b) Percent of class:
683 Capital Management, LLC - 5.09%
683 Capital Partners, LP - 5.09%
Ari Zweiman - 5.09%
--------------------------------------------------------------------
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote
683 Capital Management, LLC - 0
683 Capital Partners, LP - 0
Ari Zweiman - 0
--------------------------------------------------------------------
(ii) Shared power to vote or to direct the vote
683 Capital Management, LLC - 502,563
683 Capital Partners, LP - 502,563
Ari Zweiman - 502,563
--------------------------------------------------------------------
(iii) Sole power to dispose or to direct the
disposition of
683 Capital Management, LLC - 0
683 Capital Partners, LP - 0
Ari Zweiman - 0
--------------------------------------------------------------------
(iv) Shared power to dispose or to direct the
disposition of
683 Capital Management, LLC - 502,563
683 Capital Partners, LP - 502,563
Ari Zweiman - 502,563
--------------------------------------------------------------------
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities check the following [].
N/A
----------------------------------------------------------------------
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to
direct the receipt of dividends from, or the proceeds from the sale of, such
securities, a statement to that effect should be included in response to this
item and, if such interest relates to more than five percent of the class, such
person should be identified. A listing of the shareholders of an investment
company registered under the Investment Company Act of 1940 or the beneficiaries
of employee benefit plan, pension fund or endowment fund is not required.
N/A
----------------------------------------------------------------------
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company or Control
Person.
If a parent holding company or Control person has filed this schedule,
pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an
exhibit stating the identity and the Item 3 classification of the relevant
subsidiary. If a parent holding company or control person has filed this
schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating
the identification of the relevant subsidiary.
N/A
----------------------------------------------------------------------
Item 8. Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to ss.240.13d-1(b)(1)(ii)(J),
so indicate under Item 3(j) and attach an exhibit stating the identity and Item
3 classification of each member of the group. If a group has filed this schedule
pursuant to ss.240.13d-1(c) or ss.240.13d-1(d), attach an exhibit stating the
identity of each member of the group.
N/A
----------------------------------------------------------------------
Item 9. Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating
the date of the dissolution and that all further filings with respect to
transactions in the security reported on will be filed, if required, by members
of the group, in their individual capacity. See Item 5.
N/A
----------------------------------------------------------------------
Item 10. Certifications.
By signing below the Reporting Person certifies that, to the best of his
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having such purpose or
effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct. April 1, 2011
----------------------------------------
(Date)
683 Capital Management, LLC*
By: /s/ Ari Zweiman
----------------------
Name: Ari Zweiman
Title: Authorized Person
683 Capital Partners, LP*
By: /s/ Ari Zweiman
----------------------
Name: Ari Zweiman
Title: Authorized Person
Ari Zweiman*
/s/ Ari Zweiman
----------------------
* The Reporting Person disclaims beneficial ownership over the securities
reported herein except to the extent of the reporting persons' pecuniary
interest therein.
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative other than an executive
officer or general partner of the filing person, evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See s.240.13d-7 for other
parties for whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).
EXHIBIT A
AGREEMENT
The undersigned agree that this Schedule 13G dated April 1, 2011 relating
to the Common Stock of Furiex Pharmaceuticals, Inc. shall be filed on behalf of
the undersigned.
683 Capital Management, LLC
By: /s/ Ari Zweiman
----------------------
Name: Ari Zweiman
Title: Authorized Person
683 Capital Partners, LP
By: /s/ Ari Zweiman
----------------------
Name: Ari Zweiman
Title: Authorized Person
Ari Zweiman
/s/ Ari Zweiman
--------------------------
SK 25603 0002 1185068